Viret F - Search Results

1

Phase I study of pegylated liposomal doxorubicin (Caelyx) in combination with carboplatin in patients with advanced solid tumors.

Gonçalves A, Braud AC, Viret F, Genre D, Gravis G, Tarpin C, Giovannini M, Maraninchi D, Viens P. Gonçalves A, et al. Among authors: viret f. Anticancer Res. 2003 Jul-Aug;23(4):3543-8. Anticancer Res. 2003. PMID: 12926104 Clinical Trial.

2

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings.

Kubicka S, Greil R, André T, Bennouna J, Sastre J, Van Cutsem E, von Moos R, Osterlund P, Reyes-Rivera I, Müller T, Makrutzki M, Arnold D; ML18147 study investigators including AIO, GERCOR, FFCD, UNICANCER GI, TTD, BGDO, GEMCAD, and AGMT groups. Kubicka S, et al. Ann Oncol. 2013 Sep;24(9):2342-9. doi: 10.1093/annonc/mdt231. Epub 2013 Jul 12. Ann Oncol. 2013. PMID: 23852309 Free article. Clinical Trial.

3

Positive selection of CD34+ peripheral blood progenitor cells in patients with low-grade lymphoid malignancies and bone marrow involvement.

Viret F, Blaise D, Bouabdallah R, Stoppa AM, Novakovitch G, Faucher C, Vey N, Camerlo J, Oziel-Taieb S, Ladaique P, Gastaut JA, Maraninchi D, Chabannon C. Viret F, et al. Hematol Cell Ther. 1999 Feb;41(1):5-11. doi: 10.1007/s00282-999-0005-y. Hematol Cell Ther. 1999. PMID: 10193640

4

High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation.

Mohty M, Faucher C, Vey N, Stoppa AM, Viret F, Chabbert I, Chabannon C, Bouabdallah R, Ladaique P, Collet L, Zandotti C, Maraninchi D, Blaise D. Mohty M, et al. Among authors: viret f. Bone Marrow Transplant. 2000 Aug;26(3):251-5. doi: 10.1038/sj.bmt.1702509. Bone Marrow Transplant. 2000. PMID: 10967562 Clinical Trial.

5

Detection of epithelial cells in hematopoietic organs of patients with breast cancer. Physiopathological significance and clinical consequences.

Chabannon C, Olivero S, Viret F, Arnoulet C, Sainty D, Maraninchi D, Viens P. Chabannon C, et al. Among authors: viret f. Acta Haematol. 2001;105(3):166-71. doi: 10.1159/000046560. Acta Haematol. 2001. PMID: 11463991 Review.

6

Transient detection of beta-galactosidase activity in hematopoietic cells, following reinjection of retrovirally marked autologous blood progenitors in patients with breast or ovarian cancer receiving high-dose chemotherapy.

Bagnis C, Chabannon C, Gravis G, Imbert AM, Maroc C, Bardin F, Ladaique P, Viret F, Genre D, Faucher C, Stoppa AM, Vey N, Blaise D, Maraninchi D, Viens P, Mannoni P. Bagnis C, et al. Among authors: viret f. Exp Hematol. 2002 Feb;30(2):108-15. doi: 10.1016/s0301-472x(01)00773-1. Exp Hematol. 2002. PMID: 11823045 Free article.

7

Retinoids, cisplatin and interferon-alpha in recurrent or metastatic cervical squamous cell carcinoma: clinical results of 2 phase II trials.

Braud AC, Gonzague L, Bertucci F, Genre D, Camerlo J, Gravis G, Goncalves A, Moutardier V, Viret F, Maraninchi D, Viens P. Braud AC, et al. Among authors: viret f. Eur Cytokine Netw. 2002 Jan-Mar;13(1):115-20. Eur Cytokine Netw. 2002. PMID: 11956030 Free article. Clinical Trial.

8

Recovery of lymphocyte and dendritic cell subsets following reduced intensity allogeneic bone marrow transplantation.

Mohty M, Gaugler B, Faucher C, Sainty D, Lafage-Pochitaloff M, Vey N, Bouabdallah R, Arnoulet C, Gastaut JA, Viret F, Wolfers J, Maraninchi D, Blaise D, Olive D. Mohty M, et al. Among authors: viret f. Hematology. 2002 Jun;7(3):157-64. doi: 10.1080/10245330210000013898. Hematology. 2002. PMID: 12243978 Free article. Clinical Trial.

9

Intensive sequential dose dense chemotherapy with stem cell support as first-line treatment in advanced ovarian carcinoma: a phase II study.

Viret F, Bertucci F, Genre D, Gravis G, Chabannon C, Conte M, Houvenaeghel G, Maraninchi D, Viens P. Viret F, et al. Bone Marrow Transplant. 2002 Dec;30(12):879-84. doi: 10.1038/sj.bmt.1703762. Bone Marrow Transplant. 2002. PMID: 12476280 Clinical Trial.

10

Phase I and pharmacokinetic study of escalating dose of docetaxel administered with granulocyte colony-stimulating factor support in adult advanced solid tumors.

Gonçalves A, Viret F, Ciccolini J, Genre D, Gravis G, Giovanini M, Camerlo J, Catalin J, Maraninchi D, Viens P. Gonçalves A, et al. Among authors: viret f. Clin Cancer Res. 2003 Jan;9(1):102-8. Clin Cancer Res. 2003. PMID: 12538457 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters